Neng Zhu Selected Research

Pathologic Processes

1/2019

ANGPTL3: a novel biomarker and promising therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neng Zhu Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2008
6	Inflammation (Inflammations) 01/2022 - 07/2013
4	Atherosclerosis 01/2020 - 09/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 11/2020
2	Carcinogenesis 11/2021 - 01/2018
2	Hyperplasia 01/2021 - 01/2019
2	Obesity 12/2019 - 01/2018
2	Sepsis (Septicemia) 08/2014 - 07/2013
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Cachexia 12/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Neointima 01/2019
1	Pathologic Processes 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2018
1	Necrosis 07/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2008

Drug/Important Bio-Agent (IBA)

8	CholesterolIBA 01/2022 - 09/2014
6	LipidsIBA 01/2022 - 03/2016
2	CytokinesIBA 11/2021 - 01/2018
2	celastrolIBA 09/2021 - 01/2021
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2021 - 01/2020
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 01/2008
2	salicylhydroxamic acid (SHAM)IBA 08/2014 - 07/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	EnzymesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2022
1	HDL LipoproteinsIBA 11/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	Liver X ReceptorsIBA 09/2021
1	ATP Binding Cassette Transporter 1IBA 09/2021
1	TriterpenesIBA 01/2021
1	AdiponectinIBA 01/2021
1	steroid receptor RNA activatorIBA 11/2020
1	LipopolysaccharidesIBA 01/2020
1	SaponinsIBA 01/2020
1	7-ketocholesterolIBA 01/2020
1	CyclodextrinsIBA 01/2020
1	AldehydesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2020
1	AdipokinesIBA 12/2019
1	Thyroid HormonesIBA 01/2019
1	LeptinIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 08/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016
1	p38 Mitogen-Activated Protein KinasesIBA 08/2016
1	Caveolin 1IBA 03/2016
1	Ezetimibe (Zetia)FDA Link 02/2016
1	sodium bisulfide (NaHS)IBA 08/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2014
1	Interleukin-10 (Interleukin 10)IBA 08/2014
1	ImmunosorbentsIBA 07/2013
1	urinastatin (MR 20)IBA 07/2013
1	InterleukinsIBA 07/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Drug Therapy (Chemotherapy) 12/2019